Telehealth services available in Florida & Puerto Rico  ·  Book a Consultation Florida & Puerto Rico  ·  Book Now

Weight Loss GLP-1

Price range: $200.00 through $380.00

Medically supervised100% telehealthPrescription onlyApproval required

A medically supervised weight-loss treatment designed to support appetite control and metabolic balance. Through a personalized telehealth evaluation, eligible patients receive customized dosing along with professional guidance to support sustainable weight management.

What’s Included
  • Initial telehealth consultation
  • Weight Loss GLP-1 medication for 4 weeks (if approved)
  • Fat-burning support for 4 weeks
  • 1-month program duration
  • Ongoing medical supervision

Select your dose

Your provider may adjust it after your teleconsultation.

Learn More
What Is Compounded Semaglutide?

Compounded semaglutide is a customized formulation prepared by a licensed compounding pharmacy and prescribed by a qualified healthcare provider. It is designed to support weight management when combined with a reduced-calorie diet and healthy lifestyle habits. Semaglutide belongs to a class of medications known as GLP-1 receptor agonists, which play an important role in appetite regulation and metabolic function. Compounded formulations allow for individualized dosing as determined by a licensed provider following a telehealth evaluation.

How Does Semaglutide Work?

Semaglutide works by mimicking a naturally occurring hormone called GLP-1 (glucagon-like peptide-1), which helps regulate appetite and blood sugar levels. This medication may support weight management by:

  • Reducing appetite and hunger signals
  • Increasing feelings of fullness after meals
  • Slowing gastric emptying to help reduce food intake
  • Supporting healthy blood sugar regulation

These effects may help patients develop healthier eating patterns over time.

Medical Supervision & Safety

All patients must complete an online intake form and undergo review by a licensed healthcare provider before starting treatment. Eligibility is determined based on medical history, current health status, and clinical guidelines. Compounded semaglutide is available by prescription only and requires medical approval. Ongoing follow-up and support may be provided as part of the program.

Important Safety Disclosure

Compounded semaglutide is not FDA-approved; however, it is prepared by licensed compounding pharmacies in accordance with applicable regulations. Individual results may vary.

Who Should Not Use Semaglutide?

Semaglutide may not be appropriate for individuals who:

  • Have a personal or family history of medullary thyroid carcinoma (MTC)
  • Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Are pregnant, breastfeeding, or planning to become pregnant
  • Have certain gastrointestinal conditions or a history of pancreatitis

A licensed healthcare provider will determine eligibility based on medical evaluation.

Related Products

Language